Clinical trial
Evaluation of the Effect of Pramlintide on Satiety and Food Intake
NCT00042601 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00042601 |
|---|---|
| Title | Evaluation of the Effect of Pramlintide on Satiety and Food Intake |
| Official title | A Single Center, Randomized, Double-blind, Placebo-controlled, Two-period, Crossover Study Evaluating the Acute Effect of Pramlintide on Satiety and Food Intake in Normal-weight and Obese Non-diabetic Subjects and in Insulin Treated Subjects With Type 1 and Type 2 Diabetes Mellitus |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 1, Type 2 |
| Intervention type | Drug |
| Interventions | Pramlintide acetate, Placebo |
| Enrollment | 51 |
| Start date | Jul 1, 2002 |
| Primary completion | Oct 1, 2003 |
| Completion | Oct 1, 2003 |
| First posted | Aug 5, 2002 |
| Last update posted | Oct 21, 2015 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: